Westside Investment Management Inc. Cuts Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE)

Westside Investment Management Inc. decreased its position in Pulse Biosciences, Inc. (NASDAQ:PLSE) by 5.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 32,160 shares of the company’s stock after selling 2,015 shares during the period. Westside Investment Management Inc.’s holdings in Pulse Biosciences were worth $280,000 at the end of the most recent quarter.

Separately, PNC Financial Services Group Inc. purchased a new stake in shares of Pulse Biosciences during the fourth quarter worth about $242,000. 76.95% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Pulse Biosciences

In other Pulse Biosciences news, CEO Burke Thomas Barrett acquired 10,000 shares of the company’s stock in a transaction that occurred on Monday, May 20th. The stock was bought at an average price of $8.56 per share, with a total value of $85,600.00. Following the purchase, the chief executive officer now owns 10,000 shares in the company, valued at $85,600. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 71.50% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Pulse Biosciences to a “sell” rating in a research note on Thursday, June 27th.

Pulse Biosciences Price Performance

PLSE stock opened at $11.54 on Thursday. The firm has a 50-day simple moving average of $10.32 and a 200-day simple moving average of $9.58. Pulse Biosciences, Inc. has a 52 week low of $3.78 and a 52 week high of $14.96.

Pulse Biosciences (NASDAQ:PLSE) last released its earnings results on Tuesday, May 7th. The company reported ($0.17) EPS for the quarter.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.